Advertisement

Author | Caroline Richards

903 W UNIVERSITY PKWY

Articles

2023: What ophthalmologists in Europe anticipate for the year ahead

Members of the Ophthalmology Times Europe® Editorial Advisory Board were asked to predict developments in their ophthalmic specialties and interests for 2023. A focus is our ageing population, while efficiency and productivity are also on their minds. The board members agree that one of the major challenges in the year to come will be the large number of patients awaiting diagnosis and treatment, which is only going to increase with the rising average life expectancy worldwide.

Investigating Stargardt: RNA, gene therapy options for patients

Dr Carel Hoyng divulges the main takeaways from his Angiogenesis presentation, including the origins of Stargardt disease, correct diagnosis, ongoing gene therapy trials and the future of therapy.

Ophthalmic challenges in 2022: Automation developments, pandemic backlogs and regulatory issues expected

Four members of the Ophthalmology Times Europe® Editorial Advisory Board consider the challenges and opportunities that lie ahead in Europe in 2022.

Advertisement
Advertisement